Philipp Kümpers Selected Research

symmetric dimethylarginine

1/2020	Symmetric dimethylarginine in dysfunctional high-density lipoprotein mediates endothelial glycocalyx breakdown in chronic kidney disease.
1/2017	The role of laser Doppler flowmetry tests, serum angiopoietin-2, asymmetric and symmetric dimethylarginine to predict outcome in chronic kidney disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Philipp Kümpers Research Topics

Disease

20	Sepsis (Septicemia) 04/2024 - 01/2008
13	Critical Illness (Critically Ill) 01/2023 - 01/2008
11	Acute Kidney Injury (Acute Renal Failure) 03/2022 - 01/2010
9	Inflammation (Inflammations) 08/2023 - 10/2007
7	Infections 08/2022 - 01/2009
6	COVID-19 04/2024 - 11/2021
5	Chronic Renal Insufficiency 12/2022 - 04/2008
5	Endotoxemia 12/2012 - 01/2009
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2017 - 05/2009
4	Multiple Organ Failure (MODS) 05/2012 - 03/2010
3	Pneumonia (Pneumonitis) 08/2023 - 03/2008
3	Atherosclerosis 01/2020 - 05/2009
3	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2012 - 01/2009
2	Septic Shock (Toxic Shock Syndrome) 12/2021 - 08/2009
2	Vascular Diseases (Vascular Disease) 01/2020 - 05/2012
2	Hypertension (High Blood Pressure) 05/2012 - 08/2009
2	Coronary Disease (Coronary Heart Disease) 05/2012 - 05/2009
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2010 - 09/2008
2	Body Weight (Weight, Body) 07/2009 - 04/2008
1	Anosmia 10/2022
1	Fatigue 10/2022
1	Myalgia 10/2022
1	Cough 10/2022
1	Waterhouse-Friderichsen Syndrome 08/2022
1	Bites and Stings (Sting) 08/2022
1	Bacteremia 01/2022
1	Cytokine Release Syndrome 12/2021
1	Thrombosis (Thrombus) 12/2021
1	Wounds and Injuries (Trauma) 11/2021
1	Pathologic Neovascularization 11/2021
1	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 02/2018
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2018
1	Venous Thromboembolism 01/2018
1	Autosomal Dominant Polycystic Kidney (ADPKD) 01/2018
1	Pulmonary Embolism 01/2018

Drug/Important Bio-Agent (IBA)

20	Angiopoietin-2IBA 12/2021 - 01/2008
13	Biomarkers (Surrogate Marker)IBA 08/2023 - 01/2008
8	Angiopoietin-1IBA 01/2013 - 01/2008
7	Phenobarbital (Luminal)FDA Link 12/2022 - 06/2014
6	TIE-2 Receptor (Receptor, TIE 2)IBA 11/2019 - 01/2008
6	AngiopoietinsIBA 02/2018 - 01/2008
4	Anti-Bacterial Agents (Antibiotics)IBA 08/2022 - 01/2017
4	EnzymesIBA 01/2022 - 09/2008
4	Proteins (Proteins, Gene)FDA Link 12/2021 - 07/2009
4	CytokinesIBA 11/2021 - 01/2009
4	CarbohydratesIBA 01/2020 - 05/2017
4	C-Reactive ProteinIBA 01/2017 - 07/2009
3	Oxygen (Dioxygen)IBA 10/2022 - 01/2008
3	LigandsIBA 02/2018 - 01/2008
3	AlbuminsIBA 02/2016 - 07/2009
2	Adrenal Cortex Hormones (Corticosteroids)IBA 08/2022 - 03/2008
2	heparanaseIBA 01/2022 - 11/2019
2	Heparitin Sulfate (Heparan Sulfate)IBA 12/2021 - 11/2019
2	IronIBA 11/2021 - 07/2009
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2021 - 01/2013
2	symmetric dimethylarginineIBA 01/2020 - 01/2017
2	VasculotideIBA 02/2016 - 06/2011
2	Peptides (Polypeptides)IBA 02/2016 - 06/2011
2	Lipocalin-2IBA 02/2014 - 01/2010
2	pro-brain natriuretic peptide (1-76)IBA 01/2013 - 04/2008
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2013 - 01/2009
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2013 - 08/2009
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2012 - 01/2009
1	Interleukin-6 (Interleukin 6)IBA 04/2024
1	tocilizumab (atlizumab)FDA Link 04/2024
1	GlycosaminoglycansIBA 08/2023
1	dimethylmethylene blueIBA 08/2023
1	VaccinesIBA 01/2023
1	ProteomeIBA 11/2022
1	Meropenem (Merrem)FDA LinkGeneric 08/2022
1	ElectrolytesIBA 03/2022
1	vasectrin IIIIBA 01/2022
1	vasectrin II (VS II)IBA 01/2022
1	Heparin (Liquaemin)FDA LinkGeneric 01/2022
1	GlucuronidaseIBA 12/2021
1	Pathogen-Associated Molecular Pattern MoleculesIBA 12/2021
1	Fibrin Fibrinogen Degradation ProductsIBA 11/2021
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 11/2021
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2021
1	Interleukin-1 (Interleukin 1)IBA 11/2021
1	HDL LipoproteinsIBA 01/2020
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2018
1	fibrin fragment D (D-dimer)IBA 01/2018
1	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2017

Therapy/Procedure

7	Therapeutics 08/2022 - 01/2009
5	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2022 - 01/2010
3	Resuscitation 01/2023 - 11/2021
3	Artificial Respiration (Mechanical Ventilation) 08/2022 - 05/2012
2	Plasma Exchange 08/2022 - 11/2010
2	Ligation 12/2021 - 08/2011
2	Critical Care (Surgical Intensive Care) 01/2017 - 01/2010
2	Renal Dialysis (Hemodialysis) 01/2016 - 01/2015
2	Kidney Transplantation 01/2015 - 05/2009
2	Hematopoietic Stem Cell Transplantation 05/2010 - 09/2008
1	Continuous Renal Replacement Therapy 08/2022
1	Antibiotic Prophylaxis 08/2022
1	Extracorporeal Membrane Oxygenation 08/2022
1	Splenectomy 08/2022
1	Liver Transplantation 01/2019
1	Lasers (Laser) 01/2017